Banque Pictet & Cie’s Jazz Pharmaceuticals JAZZ Stock Holding History

Banque Pictet & Cie’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$378K	–	362
2026 Q1	$378K	Buy	+2,000	New	+$350K	﹤0.01%	324
2020 Q2	–	Sell	-17,943	Closed	-$1.79M	–	339
2020 Q1	$1.79M	Sell	17,943 -2,941	-14%	-$380K	0.04%	187
2019 Q4	$3.12M	Buy	+20,884	New	+$2.84M	0.05%	180

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Banque Pictet & Cie's JAZZ Position: Q2 2026 in Review

Banque Pictet & Cie sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 2,000 shares — an estimated $378K sold.

Banque Pictet & Cie first reported a position in JAZZ in Q4 2019 and held it in 3 quarters. The position peaked at $3.12M in Q4 2019. 333 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Banque Pictet & Cie reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Banque Pictet & Cie sold 2,000 Jazz Pharmaceuticals shares in Q2 2026, an estimated $378K.
Banque Pictet & Cie first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 3 quarters.
Banque Pictet & Cie's Jazz Pharmaceuticals position peaked at $3.12M in Q4 2019.
333 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.